C22orf13 anticorps (AA 51-150) (Biotin)

N° du produit ABIN1700921

Détail du produit anti-C22orf13 anticorps (Biotin)

Antigène: C22orf13 (GUCD1) (Guanylyl Cyclase Domain Containing 1 (GUCD1))

Épitope: AA 51-150

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp C22orf13 est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Humain

Homologie: Mouse,Rat,Dog,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human C22orf13

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur C22orf13

Antigène: C22orf13 (GUCD1) (Guanylyl Cyclase Domain Containing 1 (GUCD1))

Autre désignation: C22orf13 (GUCD1 Produits)

Synonymes: anticorps C22orf13, anticorps LLN4, anticorps 1110038D17Rik, anticorps C17H22orf13, anticorps wu:fi27d12, anticorps zgc:152874, anticorps guanylyl cyclase domain containing 1, anticorps GUCD1, anticorps Gucd1, anticorps gucd1

Sujet:

Synonyms: C22orf13, CG13760 gene product [Drosophila melanogaster] homolog, Chromosome 22 open reading frame 13, CV013_HUMAN, LLN4, MGC1842, OTTHUMP00000198388, Protein LLN4, Uncharacterized protein C22orf13.

Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf13 gene product has been provisionally designated C22orf13 pending further characterization.

ID gène: 83606